Coloplast A/S (OTCMKTS:CLPBY) Sees Large Increase in Short Interest

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 80,200 shares, a growth of 27.7% from the October 15th total of 62,800 shares. Based on an average daily trading volume, of 120,000 shares, the short-interest ratio is currently 0.7 days.

Coloplast A/S Stock Down 0.8 %

Shares of OTCMKTS CLPBY traded down $0.10 during mid-day trading on Friday, hitting $12.78. The company had a trading volume of 91,192 shares, compared to its average volume of 129,191. The business’s 50-day simple moving average is $13.12 and its 200-day simple moving average is $12.85. The company has a quick ratio of 0.56, a current ratio of 0.85 and a debt-to-equity ratio of 1.00. Coloplast A/S has a 12 month low of $10.61 and a 12 month high of $14.34.

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) last issued its earnings results on Tuesday, November 5th. The company reported $0.08 EPS for the quarter. Coloplast A/S had a return on equity of 31.17% and a net margin of 18.69%. The business had revenue of $1.02 billion during the quarter. As a group, research analysts anticipate that Coloplast A/S will post 0.38 earnings per share for the current fiscal year.

Coloplast A/S Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, December 20th. Investors of record on Monday, December 9th will be paid a $0.2435 dividend. The ex-dividend date of this dividend is Monday, December 9th. This is a boost from Coloplast A/S’s previous dividend of $0.05. Coloplast A/S’s payout ratio is presently 27.27%.

Coloplast A/S Company Profile

(Get Free Report)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.

Further Reading

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.